Danish pharmaceutical giant Novo Nordisk has secured a court order to freeze the worldwide assets of Singapore-based KBP Biosciences and its founder Huang Zhenhua, amid a legal battle over an ...

SINGAPORE: A local biotech company, which is being sued by Danish pharmaceutical company Novo Nordisk for suspected fraud, has had its global assets frozen.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best ...

CardCash.com, Giftify's secondary gift card exchange platform, provides consumers with an innovative approach to reduce rising out-of-pocket expenses for increasingly popular GLP-1 medications. The ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, ...

Polar Capital Global Healthcare, which is co-managed by James Douglas, currently trades at a 3pc discount to its assets.

Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...

Novo Nordisk is seeking up to US$830 million (S$1.1 billion) in damages from KBP Biosciences, according to a ruling by a ...

Pharmaceutical giant Novo Nordisk is seeking as much as US$830 million (S$1.1 billion) in damages in an application to a ...